Monthly Archives: October 2013
Brosch direct has been an established and trusted supplier to over 22,000 medical professionals since 1989.
With trained and experienced sales staff and a warehouse facility well stocked we are able to promptly and efficiently meet our customer’s needs and pride ourselves in supporting every sale with first class customer support. Attention to product supply combined with our first-class sales support is what has made Brosch direct the market leading company it is today.
Ever since my injury three years ago I have been determined to show the world that people with disabilities can be just as happy, independent and productive as those without disabilities. But is it possible that showing such positivity could mask our daily hardships to the point that the urgency for a cure is diminished?
Don’t get me wrong, it’s important that society knows that we are more able than most would imagine. But sometimes it feels like that is the only message we’re getting out. What about the desire for a cure?
Alabama and other states are slow to join federal programs aimed at getting young people care they need at home
Paul Boyd has two lives.
In one life, Boyd is a graduate student in counseling at the University of Montevallo, a small liberal-arts school about 30 minutes from where he lives. After class he sometimes sits on the porch of a coffee shop talking with a group of locals and college students.
In his other life, the 37-year-old Boyd is a resident of Chandler Health and Rehab, a nursing home in Alabaster, Ala. He drives the hallways in his sip-and-puff wheelchair, chatting with older residents like Thelma, who clutches a plastic baby doll to her chest.
NEWARK, Calif., Oct. 2, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) announced today that the U.S. Food and Drug Administration (FDA) has authorized the Company’s Investigational New Drug (IND) application for clinical testing of the Company’s proprietary HuCNS-SC® human neural stem cells as a treatment for spinal cord injury. As a first action under this IND, the Company is working to open U.S. sites for its Phase I/II clinical trial for chronic spinal cord injury, which is currently underway in Switzerland and Canada.
bTizzy is a one-stop shop for all things disability. From product and service offerings made by people with disabilities (PWD) to an extensive information hub featuring radio, community services and invaluable references, bTizzy’s ultimate mission is to increase economic opportunities and create positive social change for PWD.